ECM
TNDM icon

Everence Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Everence Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,376
Closed -$150K – 838
2025
Q3 		$150K Buy
+12,376
New +$168K 0.01% 789
2024
Q4 		– Sell
-11,950
Closed -$507K – 1028
2024
Q3 		$507K Buy
11,950
+2,930
+32% +$124K 0.03% 425
2024
Q2 		$331 Hold
9,020
– – 0.02% 514
2024
Q1 		$319 Hold
9,020
– – 0.02% 542
2023
Q4 		$267K Buy
+9,020
New +$187K 0.02% 592

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Everence Capital Management's TNDM Position: Q4 2025 in Review

Everence Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 12,376 shares — an estimated $150K sold.

Everence Capital Management first reported a position in TNDM in Q4 2023 and held it in 5 quarters. The position peaked at $507K in Q3 2024. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Everence Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Everence Capital Management sold 12,376 Tandem Diabetes Care shares in Q4 2025, an estimated $150K.
  • Everence Capital Management first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 5 quarters.
  • Everence Capital Management's Tandem Diabetes Care position peaked at $507K in Q3 2024.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Everence Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.